MAPT and Alzheimer disease: Studies such as those by Lu et al. and Tokuraku et al. have explored the development of QD-based fluorescence resonance energy transfer (FRET) aptasensors and nanoprobes, respectively, for the simultaneous detection of AD biomarkers such as Aβ oligomers and tau protein [14,28].